4min chapter

Blood Cancer Talks cover image

Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin

Blood Cancer Talks

CHAPTER

Importance of MRD Negativity in Myeloma and Trial-Level Surrogacy Analysis

This chapter emphasizes the benefits of achieving minimal residual disease negativity in myeloma patients and explores the concept of trial-level surrogacy to analyze correlations between MRD, progression-free survival, and overall survival. It also discusses advancements in measuring MRD in myeloma patients using more sensitive detection technologies.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode